BAJAJ BROKING
Lupin's Somerset, NJ facility, inspected by the FDA from May 7 to May 17, 2024, received Form-483 with six observations. The company's Q4 FY24 saw a 41.38% net profit drop to ₹359.43 crore on a 3.64% revenue decline to ₹4895.11 crore.
Lupin Limited, a pharmaceutical company known for its innovation, underwent a pre-approval inspection by the US Food and Drug Administration (FDA) at its manufacturing facility in Somerset, New Jersey.
Explore: Lupin Limited Share Price
The inspection was carried out from May 7 to May 17, 2024, and resulted in the issuance of a Form-483 by the FDA. This form highlighted six observations made by the inspectors regarding potential regulatory violations.
Lupin promptly responded to the FDA's observations, pledging to address them comprehensively. As per regulatory requirements, the company will provide a detailed corrective action plan within the specified timeframe to ensure compliance with FDA regulations.
Additional Read: Share Market News
In the fourth quarter of FY24, Lupin witnessed a significant decline in its consolidated net profit, plummeting by 41.38% to ₹359.43 crore. Additionally, the company's revenue from operations saw a decrease of 3.64% to ₹4895.11 crore compared to Q4 FY23.
Lupin disclosed the outcome of the FDA inspection in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This communication was made to the Bombay Stock Exchange (BSE), ensuring transparency and adherence to regulatory norms.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Godrej Properties Acquires 53-Acre Land in Kolkata for ₹500 Crore
21 Nov, 2024 | 2 Min. read
GNFC Partners with INEOS to Build 600kt Acetic Acid Plant in Gujarat
21 Nov, 2024 | 2 Min. read
Adani Infra Launches Open Offer to Buy 26% Stake in PSP Projects
21 Nov, 2024 | 2 Min. read
UPL’s Advanta Secures $350M Investment from Alpha Wave Global
21 Nov, 2024 | 2 Min. read
Commodities Market Today | Crude Oil Drops, Gold Rises, Silver Falls in Market Moves
21 Nov, 2024 | 1 Min. read
Share Market Today | Gift Nifty Signals Weak Opening, Indian Markets May Consolidate
21 Nov, 2024 | 4 Min. read
Gold Rate Today | Gold Gains 0.9% to $2,653.50, Silver Drops 1%
21 Nov, 2024 | 2 Min. read
Know C2C Advanced Systems IPO Review, Objective & Applying Process
21 Nov, 2024 | 1 Min. read
Explore the List of Top Education Stocks in India
21 Nov, 2024 | 8 Min. read
What are Reverse Stock Splits: Meaning & Example
21 Nov, 2024 | 7 Min. read
How to Apply Under Shareholders' Quota in NTPC Green Energy IPO?
21 Nov, 2024 | 1 Min. read
What is Personal Finance? Meaning & Importance
21 Nov, 2024 | 4 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading